Tulane University researchers have developed a first-of-its-kind handheld diagnostic device that can deliver rapid, accurate ...

The U.S. Food and Drug Administration on Friday granted authorization to market the first test that can be performed entirely ...

Five home-testing devices for obstructive sleep apnoea hypopnoea syndrome (OSAHS), a potentially dangerous condition affecting 2.5 million adults in the UK, have been recommended for NHS use by NICE.

The global point of care blood testing devices market is on a rapid upward trajectory, with projections indicating a remarkable expansion to an estimated value of USD 49,973.6 million by 2032. This ...